Your browser doesn't support javascript.
loading
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.
Chabanon, Roman M; Muirhead, Gareth; Krastev, Dragomir B; Adam, Julien; Morel, Daphné; Garrido, Marlène; Lamb, Andrew; Hénon, Clémence; Dorvault, Nicolas; Rouanne, Mathieu; Marlow, Rebecca; Bajrami, Ilirjana; Cardeñosa, Marta Llorca; Konde, Asha; Besse, Benjamin; Ashworth, Alan; Pettitt, Stephen J; Haider, Syed; Marabelle, Aurélien; Tutt, Andrew Nj; Soria, Jean-Charles; Lord, Christopher J; Postel-Vinay, Sophie.
Afiliação
  • Chabanon RM; Université Paris Saclay, Université Paris-Sud, Faculté de médicine, Le Kremlin Bicêtre, Paris, France.
  • Muirhead G; ATIP-Avenir group, Inserm U981, Gustave Roussy, Villejuif, France.
  • Krastev DB; The Breast Cancer Now Toby Robins Breast Cancer Research Centre and.
  • Adam J; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
  • Morel D; The Breast Cancer Now Toby Robins Breast Cancer Research Centre and.
  • Garrido M; The Breast Cancer Now Toby Robins Breast Cancer Research Centre and.
  • Lamb A; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
  • Hénon C; ATIP-Avenir group, Inserm U981, Gustave Roussy, Villejuif, France.
  • Dorvault N; Université Paris Saclay, Université Paris-Sud, Faculté de médicine, Le Kremlin Bicêtre, Paris, France.
  • Rouanne M; ATIP-Avenir group, Inserm U981, Gustave Roussy, Villejuif, France.
  • Marlow R; ATIP-Avenir group, Inserm U981, Gustave Roussy, Villejuif, France.
  • Bajrami I; Sage Bionetworks, Seattle, Washington, USA.
  • Cardeñosa ML; Université Paris Saclay, Université Paris-Sud, Faculté de médicine, Le Kremlin Bicêtre, Paris, France.
  • Konde A; ATIP-Avenir group, Inserm U981, Gustave Roussy, Villejuif, France.
  • Besse B; ATIP-Avenir group, Inserm U981, Gustave Roussy, Villejuif, France.
  • Ashworth A; Université Paris Saclay, Université Paris-Sud, Faculté de médicine, Le Kremlin Bicêtre, Paris, France.
  • Pettitt SJ; Inserm U1015, Gustave Roussy, Villejuif, France.
  • Haider S; The Breast Cancer Now Research Unit, King's College London, London, United Kingdom.
  • Marabelle A; The Breast Cancer Now Toby Robins Breast Cancer Research Centre and.
  • Tutt AN; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
  • Soria JC; The Breast Cancer Now Toby Robins Breast Cancer Research Centre and.
  • Lord CJ; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, United Kingdom.
  • Postel-Vinay S; Biomedical Research Institute INCLIVA, Hospital Clinico Universitario Valencia, University of Valencia, Valencia, Spain.
J Clin Invest ; 129(3): 1211-1228, 2019 03 01.
Article em En | MEDLINE | ID: mdl-30589644
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a DNA / Endonucleases / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Proteínas de Ligação a DNA / Endonucleases / Inibidores de Poli(ADP-Ribose) Polimerases / Neoplasias Pulmonares Limite: Female / Humans Idioma: En Revista: J Clin Invest Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos